Nurix Therapeutics, Inc. (NRIX)
26.27
-0.45
(-1.68%)
USD |
NASDAQ |
Aug 24, 16:00
26.28
+0.01
(+0.04%)
After-Hours: 20:00
Nurix Therapeutics 1 Year Total Returns (Daily) : 159.1% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 159.1% |
| August 21, 2026 | 176.9% |
| August 20, 2026 | 183.8% |
| August 19, 2026 | 182.4% |
| August 18, 2026 | 163.9% |
| August 17, 2026 | 156.8% |
| August 14, 2026 | 156.2% |
| August 13, 2026 | 157.2% |
| August 12, 2026 | 165.8% |
| August 11, 2026 | 169.0% |
| August 10, 2026 | 163.0% |
| August 07, 2026 | 153.5% |
| August 06, 2026 | 141.1% |
| August 05, 2026 | 122.1% |
| August 04, 2026 | 118.9% |
| August 03, 2026 | 110.3% |
| July 31, 2026 | 106.1% |
| July 30, 2026 | 98.48% |
| July 29, 2026 | 98.49% |
| July 28, 2026 | 102.4% |
| July 27, 2026 | 103.4% |
| July 24, 2026 | 102.8% |
| July 23, 2026 | 104.1% |
| July 22, 2026 | 109.8% |
| July 21, 2026 | 108.7% |
| Date | Value |
|---|---|
| July 20, 2026 | 102.6% |
| July 17, 2026 | 91.23% |
| July 16, 2026 | 85.75% |
| July 15, 2026 | 96.30% |
| July 14, 2026 | 81.09% |
| July 13, 2026 | 82.56% |
| July 10, 2026 | 82.00% |
| July 09, 2026 | 87.33% |
| July 08, 2026 | 99.10% |
| July 07, 2026 | 97.41% |
| July 06, 2026 | 88.85% |
| July 02, 2026 | 92.68% |
| July 01, 2026 | 104.2% |
| June 30, 2026 | 113.0% |
| June 29, 2026 | 104.9% |
| June 26, 2026 | 93.41% |
| June 25, 2026 | 93.29% |
| June 24, 2026 | 61.24% |
| June 23, 2026 | 57.43% |
| June 22, 2026 | 62.32% |
| June 18, 2026 | 51.03% |
| June 17, 2026 | 50.31% |
| June 16, 2026 | 43.32% |
| June 15, 2026 | 42.83% |
| June 12, 2026 | 41.72% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Monte Rosa Therapeutics, Inc. | 185.8% |
| Gilead Sciences, Inc. | 31.20% |
| TG Therapeutics, Inc. | 90.22% |
| Cue Biopharma, Inc. | -6.46% |
| Keros Therapeutics, Inc. | -30.72% |